DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
QUEST DIAGNOSTICS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 23, 2026
$234.91−0.09 (-0.04%)
Close on Oct 19, 2026
- Market cap
- $26.31B
- P/E (TTM)
- 25.0
- Dividend yield
- –
QUEST DIAGNOSTICS INC revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DIS business | $2.98B | $2.83B | $2.74B | $2.76B | $2.70B | $2.59B | $2.56B | $2.43B | $2.33B | $2.30B | $2.22B | $2.23B | 97.9% | +10.3% |
| All other operating segments | $65.00M | $63.00M | $64.00M | $61.00M | $62.00M | $63.00M | $65.00M | $61.00M | $64.00M | $68.00M | $67.00M | $67.00M | 2.1% | +4.8% |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DIS business | $541.00M | $457.00M | $439.00M | $482.00M | $494.00M | $414.00M | $430.00M | $407.00M | $420.00M | $373.00M | $371.00M | $392.00M | +9.5% |
| All other operating segments | $10.00M | $7.00M | $8.00M | $9.00M | $7.00M | $8.00M | $10.00M | $6.00M | $8.00M | $9.00M | $8.00M | $8.00M | +42.9% |
| General corporate activities | -$92.00M | -$65.00M | -$61.00M | -$105.00M | -$63.00M | -$76.00M | -$79.00M | -$83.00M | -$73.00M | -$82.00M | -$112.00M | -$58.00M | +46.0% |
By product or service
By region
From the segment and revenue-disaggregation notes of Quest Diagnostics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.